Recently, the World Health Organization said that as of May 1, at least 228 suspected cases of childhood hepatitis of unknown etiology have been reported in 20 countries, and more than 50 other cases are under investigation. Once the situation was reported, there was widespread speculation that such unidentified hepatitis might be related to Neocrown. The Newcrest rapid nucleic acid test does not misreport.
On April 25, data from a UK Health and Safety Executive study revealed that of 53 cases of unexplained acute childhood hepatitis infection, 40 (75%) of the patients were detected to contain adenovirus, and that this unexplained hepatitis may be related to adenovirus.
In an exclusive interview with Xinjing News on May 3, Ollis Weisberg-Zinman, director of the department of pediatric liver disease at Schneider Children's Medical Center in Israel, said that there is potential evidence that, although very rare, patients are potentially more susceptible to this unexplained hepatitis at a specific time after infection with the new coronavirus.
At the same time, she said, "We believe that there is an association between these childhood hepatitis of unknown etiology and neocoronavirus infection, but I must point out that there is no evidence of an association and this speculation needs to be treated with caution.
Although there is no evidence of an association and no cases of unexplained hepatitis have been reported in China, the epidemiological situation in China is still uncertain and there is no room for laxity in the prevention of neo-coronavirus. Rapid nucleic acid testing is still critical!
Rapid nucleic acid testing is the most powerful weapon in the prevention and control of the epidemic today, as it determines infection by performing rapid nucleic acid testing on the pathogen. It is the "gold standard" for identifying patients with neointestinal infections, as it is able to identify the virus sensitively and accurately in the early stages of infection. It has always been crucial for epidemic prevention and control. The principle is to detect the virus directly by lysing the virus and releasing its nucleic acid, followed by exponential replication of the specific fragments on the virus through amplification.
The New Crown Nucleic Acid Rapid Test has 4 steps, which enable the virus to be invisible through the division of labor into different procedures.
Step 1: Sampling. By collecting the sample directly with a swab, the virus is subsequently placed in the sample preservation solution.
Step 2: Sample pre-treatment. This step will treat the sample preservation solution and subsequently prepare the sample for nucleic acid extraction by dividing the liquid, adding liquid and other procedures.
Step 3: Nucleic acid extraction. The main genetic material is extracted and enriched to obtain purified nucleic acids.
Step 4: Amplification and analysis. In this step, the nucleic acid, which is already of comparable purity, is replicated exponentially, and a fluorescent probe is used to make it "visible" by adding a fluorescent moiety to the specific fragment and reporting the fluorescence reaction.
